Parkside Financial Bank & Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12
Closed -$975 3010
2025
Q1
$975 Hold
12
﹤0.01% 2115
2024
Q4
$1.08K Hold
12
﹤0.01% 1724
2024
Q3
$1.19K Hold
12
﹤0.01% 1681
2024
Q2
$1.11K Hold
12
﹤0.01% 1639
2024
Q1
$1.14K Hold
12
﹤0.01% 1594
2023
Q4
$1.07K Sell
12
-581
-98% -$43.1K ﹤0.01% 1606
2023
Q3
$43.3K Hold
593
0.01% 661
2023
Q2
$49.3K Hold
593
0.01% 616
2023
Q1
$45.2K Hold
593
0.01% 635
2022
Q4
$49.2K Hold
593
0.01% 574
2022
Q3
$47K Buy
+593
New +$50K 0.02% 543
2022
Q2
Sell
-162
Closed -$15K 1975
2022
Q1
$15K Hold
162
﹤0.01% 917
2021
Q4
$18K Hold
162
﹤0.01% 854
2021
Q3
$20K Hold
162
0.01% 790
2021
Q2
$22K Hold
162
0.01% 758
2021
Q1
$22K Sell
162
-118
-42% -$17.7K 0.01% 750
2020
Q4
$39K Hold
280
0.01% 533
2020
Q3
$31K Hold
280
0.01% 529
2020
Q2
$31K Hold
280
0.01% 531
2020
Q1
$22K Hold
280
0.01% 551
2019
Q4
$27K Hold
280
0.01% 583
2019
Q3
$21K Hold
280
0.01% 615
2019
Q2
$25K Hold
280
0.01% 573
2019
Q1
$25K Hold
280
0.01% 537
2018
Q4
$20K Hold
280
0.01% 572
2018
Q3
$27K Hold
280
0.01% 510
2018
Q2
$27K Hold
280
0.01% 504
2018
Q1
$25K Hold
280
0.01% 507
2017
Q4
$24K Buy
+280
New +$23.5K 0.01% 524

Other funds holding XBI

Parkside Financial Bank & Trust's XBI Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 12 shares — an estimated $975 sold.

Parkside Financial Bank & Trust first reported a position in XBI in Q4 2017 and held it in 29 quarters. The position peaked at $49.3K in Q2 2023. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • Parkside Financial Bank & Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 12 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $975.
  • Parkside Financial Bank & Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 29 quarters.
  • Parkside Financial Bank & Trust's State Street SPDR S&P Biotech ETF position peaked at $49.3K in Q2 2023.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.